Trials / Completed
CompletedNCT01462136
PK Study of ACHN-490 Injection in Renally Impaired Subjects
A Phase 1 Study To Assess The Pharmacokinetics, Safety, And Tolerability of Intravenous ACHN-490 Injection in Volunteers With Varying Degrees of Renal Dysfunction Compared to Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Achaogen, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purposes of this study is to assess the relationship between renal function and pharmacokinetics of ACHN-490 Injection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ACHN-490 Injection | 7.5 mg/kg single dose administered intravenously over 30 minutes |
Timeline
- Start date
- 2011-09-01
- First posted
- 2011-10-31
- Last updated
- 2012-08-23
Source: ClinicalTrials.gov record NCT01462136. Inclusion in this directory is not an endorsement.